St. Petersburg Times
By ROBERT FARLEY
It sounds like a cosmic, FDA joke:
The Food and Drug Administration approves the antipsychotic drug Zyprexa to treat adults with schizophrenia or bipolar disorder. It becomes a market wonder, a bestseller. But the side effects turn out to be dangerous; some patients develop diabetes.
Some 30,000 people sue the manufacturer, Eli Lilly. The pharmaceutical giant shells out more than $1-billion to settle the cases.
Here comes the punch line:
Though studies show that kids are even more susceptible to Zyprexa’s dangerous side effects, now Lilly wants the government’s seal of approval for adolescents to use it. And the FDA is about to say yes…